Research & Development
Apitope is developing innovative therapeutic peptides for the potential treatment of autoimmune and allergic diseases. These peptides are designed to have the potential to treat the underlying cause of the disease rather than treating disease symptoms or non-specifically suppressing the immune system.
Apitope’s therapeutic approach is based on well-established scientific evidence showing that soluble, synthetic peptides can limit the heightened sensitivity to a specific antigen hence restoring the normal balance of the immune system.
Apitope has shown that not all peptides can suppress disease and they must behave as Apitopes™ - Antigen Processing Independent epiTOPES - in order to be effective therapeutics. Apitope’s patented, leading edge technology platform enables it to identify these peptide-based therapeutics.
